Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations
- 1 February 2005
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 7 (2), 179-191
- https://doi.org/10.1016/j.ccr.2005.01.010
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemiaBlood, 2004
- Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorderBlood, 2004
- Distinct sequences on 11q13.5 and 11q23–24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patientsGenes, Chromosomes and Cancer, 2004
- Role of FLT3 in leukemiaCurrent Opinion in Hematology, 2002
- The gift of GabFEBS Letters, 2002
- Site-Specific Incorporation of a Phosphotyrosine Mimetic Reveals a Role for Tyrosine Phosphorylation of SHP-2 in Cell SignalingMolecular Cell, 2001
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Fruit fly “leukemia”Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1998
- Drosophila awdK–pn, a homologue of the metastasis suppressor gene nm23, suppresses the Tum–I haematopoietic oncogeneNature Genetics, 1993
- Activation of the MAP kinase pathway by the protein kinase rafCell, 1992